MIRM - Mirum Pharmaceuticals, Inc.


93.04
5.240   5.632%

Share volume: 777,401
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$87.80
5.24
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-08-2024 08-07-2024 11-12-2024 02-26-2025 05-07-2025 08-06-2025 11-04-2025 02-25-2026
Total revenue 69.222 M 77.875 M 90.377 M 99.414 M 111.585 M 127.785 M 133.010 M 148.932 M
Cost of revenue 17.830 M 20.227 M 20.806 M 22.780 M 23.018 M 23.421 M 25.537 M 28.264 M
Gross profit 51.392 M 57.648 M 69.571 M 76.634 M 88.567 M 104.364 M 107.473 M 120.668 M
    12.17% 20.68% 10.15% 15.57% 17.84% 2.98% 12.28%  
Operating expenses 77.860 M 81.880 M 82.255 M 100.856 M 103.750 M 109.353 M 104.870 M 125.235 M
Selling general and admin 45.638 M 49.208 M 50.545 M 56.830 M 57.706 M 63.286 M 61.910 M 74.128 M
Research and development 32.222 M 32.672 M 31.710 M 44.026 M 46.044 M 46.067 M 42.960 M 51.107 M
Total expenses 77.860 M 81.880 M 82.255 M 100.856 M 103.750 M 109.353 M 104.870 M 125.235 M
    5.16% 0.46% 22.61% 2.87% 5.40% -4.10% 19.42%  
Operating income -26.468 M -24.232 M -12.684 M -24.222 M -15.183 M -4.989 M 2.603 M -4.567 M
Ebit -24.711 M -23.920 M -13.771 M -23.991 M -13.075 M -4.903 M 2.998 M -4.785 M
Pretax income -24.655 M -24.003 M -13.888 M -24.366 M -13.648 M -5.459 M 2.643 M -4.963 M
    -2.64% -42.14% 75.45% -43.99% -60.00% -148.42% -287.78%  
Income tax 624.000 K 635.000 K 347.000 K -576.000 K 1.029 M 402.000 K -262.000 K 767.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -25.279 M -24.638 M -14.235 M -23.790 M -14.677 M -5.861 M 2.905 M -5.730 M
    2.54% 42.22% -67.12% 38.31% 60.07% 149.56% -297.25%